2
Press Release: STADA’s Strong Growth Journey Continues in 2025
One document
more
Stories about Therapie
30 Years of European Spas: Nature, Natural Remedies and Climate Health as Europe’s Unique Strength
moreDeutsche Gesellschaft für Chirotherapie und Osteopathie e. V.
Internationally honored: Prof. Dietmar Jürgen Daichendt receives honorary doctorate for pioneering achievements in osteopathy and manual medicine
moreMaP Toolbox: Your Hub for Master Protocol Clinical Trials
moreAsklepios Kliniken GmbH & Co. KGaA
2Dr. Carl June and Dr. Michel Sadelain are being awarded the Broermann Medical Innovation Award 2025
moreRHEACELL receives EMA approval for allo-APZ2-CVU Phase 3 trial in chronic venous ulcers
more
Gerresheimer: FDA grants Tentative Approval of SQ Innovation’s Lasix® ONYU*
moreInceptor Regulates Insulin Homeostasis: A New Approach for Diabetes Therapies
moreOttobock invests in NeuroTech company ONWARD® Medical
moreRHEACELL announces FDA approval for Phase 3 study in refractory, non-curable CVU
more- 2
Fundació Puigvert validates a new tool capable of selecting the most suitable antibiotic for uncomplicated urinary tract infections within 45 minutes.
One documentmore - 10
Gerresheimer: New pictures available
more
Gerresheimer expands capacities for Medical Systems in the USA
moreDr. Reddy's subsidiary betapharm, and Theranica launch Nerivio® in Germany to provide patients with drug-free migraine treatment
moreResearch Success in Rare Disease / RHEACELL receives positive signal for accelerated stem cell development program in rare ‚Butterfly Disease‘
more- 2
Press release : People with Parkinson’s experience variations in effects of oral medicines, but lack advice, international survey reveals
One documentmore RHEACELL announces “First Patient In”: EB-Haus in Salzburg, Austria starts pivotal study for stem cell therapy for severe forms of Epidermolysis bullosa that is longed for by those affected
moreThe world's first Extended Isolated Stopflow Limb Infusion (EISLI) to treat osteosarcoma results in complete remission
more
Stem cell therapy for “Butterfly disease” / RHEACELL receives ‘Partners in Progress Award’ from debra of America for Epidermolysis Bullosa research
moreKlinik für Prostata-Therapie Heidelberg
Focal therapy for prostate cancer: Reliable diagnosis leads to gentle treatment
moreNew Ultra-Sensitive Leukemia Blood Test Delivered by Sysmex Inostics
moreInvestment breakthrough for BrainRepair UG start-up – Stem cell treatment for newborns / Dr. Metin Colpan, founder of Nasdaq listed Qiagen N.V. acquired 5% of BrainRepair UG shares worth EUR 15M
more- 2
Lindis Biotech develops immunotherapy against bladder cancer
One documentmore - 3
World Cancer Day: Start-ups at the IZB develop innovative cancer drugs and diagnostic tools
One documentmore
Merger: Newly-formed Semdor Pharma Group becomes one of Europe's leading pharmaceutical companies for narcotics and medical cannabis
moreRegulatory breakthrough for BrainRepair UG start-up - Stem cell treatment for newborns /EMA Orphan Drug Designation is followed by agreement on Paediatric Investigation Plan
more- 2
Innovation: Intelligent bacteria demonstrate high efficacy in the treatment of widespread disease irritable bowel syndrome with typical symptoms of recurrent diarrhoea, abdominal pain, bloating and constipation
more Hitachi Medical Systems Europe Holding AG
2Hitachi and Centre Léon Bérard cancer center in Lyon to launch a research collaboration in the fight against cancer with AI
moreThe development of a combination drug for immunotherapy and trends of the VC and pharmaceutical branch were introduced at the IZB
One documentmore
1